Polymyalgia Rheumatica

Ann Intern Med. 2017 May 2;166(9):ITC65-ITC80. doi: 10.7326/AITC201705020.

Abstract

This issue provides a clinical overview of polymyalgia rheumatica, focusing on risk factors, diagnosis, treatment, and practice improvement. The content of In the Clinic is drawn from the clinical information and education resources of the American College of Physicians (ACP), including MKSAP (Medical Knowledge and Self-Assessment Program). Annals of Internal Medicine editors develop In the Clinic in collaboration with the ACP's Medical Education and Publishing divisions and with the assistance of additional science writers and physician writers.

Publication types

  • Review

MeSH terms

  • Diagnosis, Differential
  • Glucocorticoids / therapeutic use
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Patient Education as Topic
  • Polymyalgia Rheumatica / diagnosis*
  • Polymyalgia Rheumatica / drug therapy*
  • Prognosis
  • Risk Factors

Substances

  • Glucocorticoids
  • Immunosuppressive Agents